Immune Biosolutions is a biotech company specialized in the discovery and engineering of chicken edible and humanized antibodies. Through its Nebula Antibody Platform, it generates recombinant antibody portfolios that can target, as well as modulate, membrane proteins. The company uses untapped chicken antibody repertoire to target conserved mammalian proteins, proprietary spatial peptides reproducing the target’s 3D conformation, phage display technologies combined with next-generation sequencing (NGS).